J&J applies for COVID-19 vaccine study in Indian adolescents

Johnson & Johnson has sought approval from Indian drug regulators to conduct a study of its COVID-19 vaccine among 12- to 17-year-olds, the company said on Friday. Conducting vaccine clinical trials among adolescents is imperative to achieve herd immunity against the coronavirus, J&J said in an emailed statement. The U.S. pharma giant had received emergency use